The compound could theoretically interact with medications affecting NAD+ metabolism, energy pathways, or the enzymes responsible for its clearance from the body
New delivery methods like GLP-1 patches and oral versus injectable formulations are also changing how these medications reach patients, which could indirectly affect eligibility standards as access models evolve
Second, they raise costs to the system, forcing patients, employers, government plans, and taxpayers to pay their high prices for far longer than necessary
Cycling Details The standard protocol is 10 consecutive days of daily injections, followed by 4 weeks off
Stephanou Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made